| |
| |
|
| Insider
Information: |
Adams Brian |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
451,836 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,088,166 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
451,836 |
|
|
| Total
Value |
$2,088,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
22
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
21
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -23.6%
|
-723.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
General Counsel and Se... |
2018-02-15 |
126,069 |
|
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
325,767 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-09-27 |
4 |
S |
$22.73 |
$6,683 |
D/D |
(294) |
62,548 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-10-28 |
4 |
S |
$21.54 |
$15,681 |
D/D |
(728) |
61,820 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2022-12-27 |
4 |
S |
$14.49 |
$4,275 |
D/D |
(295) |
61,525 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-01-12 |
4 |
AS |
$20.00 |
$199,880 |
D/D |
(9,994) |
51,531 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
85,425 |
136,956 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-01-30 |
4 |
S |
$21.56 |
$18,628 |
D/D |
(864) |
136,092 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-03-27 |
4 |
S |
$15.36 |
$5,330 |
D/D |
(347) |
135,745 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-04-28 |
4/A |
S |
$11.16 |
$21,606 |
D/D |
(1,936) |
133,809 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-04-28 |
4 |
S |
$11.16 |
$9,631 |
D/D |
(863) |
134,882 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-06-27 |
4 |
S |
$12.12 |
$3,563 |
D/D |
(294) |
133,515 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-07-28 |
4 |
S |
$11.80 |
$19,210 |
D/D |
(1,628) |
131,887 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-09-27 |
4 |
S |
$8.38 |
$2,464 |
D/D |
(294) |
131,593 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-10-30 |
4 |
S |
$6.03 |
$9,841 |
D/D |
(1,632) |
129,961 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-12-27 |
4 |
S |
$11.51 |
$3,384 |
D/D |
(294) |
129,667 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
329,667 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-01-29 |
4 |
S |
$9.64 |
$18,596 |
D/D |
(1,929) |
327,738 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-03-27 |
4 |
S |
$7.70 |
$2,680 |
D/D |
(348) |
327,390 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-04-29 |
4 |
S |
$6.38 |
$10,355 |
D/D |
(1,623) |
325,767 |
0 |
% |
|
68 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
